Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 1
1971 2
1972 1
1973 1
1975 1
1976 1
1978 1
1983 1
1984 4
1985 2
1986 3
1987 3
1988 5
1989 9
1990 3
1991 1
1992 4
1993 3
1994 8
1995 3
1996 9
1997 10
1998 10
1999 2
2000 7
2001 5
2002 3
2003 9
2004 7
2005 10
2006 11
2007 16
2008 16
2009 19
2010 6
2011 13
2012 11
2013 17
2014 21
2015 30
2016 29
2017 24
2018 25
2019 29
2020 30
2021 35
2022 47
2023 44
2024 40
2025 39

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

586 results

Results by year

Filters applied: . Clear all
Page 1
Real-world effectiveness comparison of first-line palbociclib, ribociclib or abemaciclib plus endocrine therapy in advanced HR-positive/HER2-negative BC patients: results from the multicenter PALMARES-2 study.
Provenzano L, Dieci MV, Curigliano G, Giuliano M, Botticelli A, Lambertini M, Rizzo G, Pedersini R, Sirico M, La Verde N, Gennari A, Zambelli A, Toss A, Piras M, Giordano M, Tagliaferri B, Generali D, Sartori D, Miliziano D, Menichetti A, Ligorio F, Zurlo C, Griguolo G, Berton Giachetti PP, Faso V, Corti C, Chiappe E, Scagnoli S, Pisegna S, Capasso C, De Angelis C, Arpino G, Criscitiello C, Guarneri V, Pruneri G, Mariani L, Vernieri C; PALMARES-2 Study Group. Provenzano L, et al. Among authors: giuliano m. Ann Oncol. 2025 Jul;36(7):762-774. doi: 10.1016/j.annonc.2025.03.023. Epub 2025 Apr 8. Ann Oncol. 2025. PMID: 40204155 Free article.
Efficacy and safety of ramucirumab plus carboplatin and paclitaxel in untreated metastatic thymic carcinoma: RELEVENT phase II trial (NCT03921671).
Proto C, Ganzinelli M, Manglaviti S, Imbimbo M, Galli G, Marabese M, Zollo F, Alvisi MF, Perrino M, Cordua N, Borea F, de Vincenzo F, Chella A, Cappelli S, Pardini E, Ballatore Z, Lucarelli A, Ambrosini E, Giuliano M, Pietroluongo E, Mulargiu C, Fabbri A, Prelaj A, Occhipinti M, Brambilla M, Mazzeo L, Beninato T, Vigorito R, Ruggirello M, Greco FG, Calareso G, Miliziano D, Rulli E, De Simone I, Torri V, de Braud FGM, Pasello G, De Placido P, Berardi R, Petrini I, Zucali P, Garassino MC, Lo Russo G. Proto C, et al. Among authors: giuliano m. Ann Oncol. 2024 Sep;35(9):817-826. doi: 10.1016/j.annonc.2024.06.002. Epub 2024 Jun 8. Ann Oncol. 2024. PMID: 38857846 Free article. Clinical Trial.
Toxicity profile of antibody-drug conjugates in breast cancer: practical considerations.
D'Arienzo A, Verrazzo A, Pagliuca M, Napolitano F, Parola S, Viggiani M, Caputo R, Puglisi F, Giuliano M, Del Mastro L, Arpino G, De Laurentiis M, Montemurro F. D'Arienzo A, et al. Among authors: giuliano m. EClinicalMedicine. 2023 Jul 27;62:102113. doi: 10.1016/j.eclinm.2023.102113. eCollection 2023 Aug. EClinicalMedicine. 2023. PMID: 37554126 Free PMC article. Review.
Riding the Wave of Ambivalence in Cell Biology.
Emanuele S, Giuliano M. Emanuele S, et al. Among authors: giuliano m. Int J Mol Sci. 2024 Jul 4;25(13):7348. doi: 10.3390/ijms25137348. Int J Mol Sci. 2024. PMID: 39000455 Free PMC article.
Cardio-Oncology Challenges in Elderly Patients.
Topa E, De Rosa E, Cuomo A, Curcio F, Rizza M, Elia F, Flocco V, Attanasio U, Iengo M, Fiore F, Luise MC, Arpino G, Bianco R, Carlomagno C, Giuliano M, Formisano L, Picardi M, Della Corte CM, Morgillo F, Martini G, Martinelli E, Napolitano S, Troiani T, Esposito G, Cittadini A, Iaccarino G, Rengo G, Abete P, Mercurio V, Tocchetti CG. Topa E, et al. Among authors: giuliano m. J Clin Med. 2025 May 7;14(9):3257. doi: 10.3390/jcm14093257. J Clin Med. 2025. PMID: 40364287 Free PMC article.
High FOXA1 levels induce ER transcriptional reprogramming, a pro-metastatic secretome, and metastasis in endocrine-resistant breast cancer.
Fu X, Pereira R, Liu CC, De Angelis C, Shea MJ, Nanda S, Qin L, Mitchell T, Cataldo ML, Veeraraghavan J, Sethunath V, Giuliano M, Gutierrez C, Győrffy B, Trivedi MV, Cohen O, Wagle N, Nardone A, Jeselsohn R, Rimawi MF, Osborne CK, Schiff R. Fu X, et al. Among authors: giuliano m. Cell Rep. 2023 Aug 29;42(8):112821. doi: 10.1016/j.celrep.2023.112821. Epub 2023 Jul 18. Cell Rep. 2023. PMID: 37467106 Free PMC article.
Symptom profile, case and symptom clustering, clinical and demographic characteristics of a multicentre cohort of 1297 patients evaluated for Long-COVID.
Floridia M, Giuliano M, Weimer LE, Ciardi MR, Agostoni P, Palange P, Rovere Querini P, Zucco S, Tosato M, Lo Forte A, Bonfanti P, Lacedonia D, Barisione E, Figliozzi S, Andreozzi P, Damiano C, Pricci F, Onder G; I. S. S. Long-COVID Study Group. Floridia M, et al. Among authors: giuliano m. BMC Med. 2024 Nov 14;22(1):532. doi: 10.1186/s12916-024-03746-9. BMC Med. 2024. PMID: 39543596 Free PMC article.
586 results